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Blood clots must be stiff to stop hemorrhage yet
elastic to buffer blood’s shear forces. Upsetting this
balance results in clot rupture and life-threatening
thromboembolism. Fibrin, the main component of
a blood clot, is formed from molecules of fibrinogen
activated by thrombin. Although it is well known
that fibrin possesses considerable elasticity, the mo-
lecular basis of this elasticity is unknown. Here, we
use atomic force microscopy (AFM) and steered mo-
lecular dynamics (SMD) to probe the mechanical
properties of single fibrinogen molecules and fibrin
protofibrils, showing that the mechanical unfolding
of their coiled-coil a helices is characterized by a
distinctive intermediate force plateau in the systems’
force-extension curve. We relate this plateau force
to a stepwise unfolding of fibrinogen’s coiled a heli-
ces and of its central domain. AFM data show that
varying pH and calcium ion concentrations alters
the mechanical resilience of fibrinogen. This study
provides direct evidence for the coiled a helices of
fibrinogen to bring about fibrin elasticity.
INTRODUCTION
Cardiothromboembolic disease, in which blood clots occlude
vessels, leading to tissue death in the brain, heart, and lungs,
is a major cause of human mortality. Blood clots arise as the
result of alterations in blood flow within the arterial system
such as in the case of an abnormal heart rhythm or within the
venous system in the deep veins of the leg during prolonged
periods of inactivity, for example, in case of the ‘‘Economy Class
Syndrome.’’ Current strategies for dealing with this disease in-
volvemeasures to prevent the clots from forming; however, there
has been little research focus aimed at preventing blood clots
from rupturing once they have already formed.
The process of blood clotting starts when fibrinogen, an abun-
dant plasma protein, is activated by thrombin to form fibrin
fibers. These fibers, together with entrapped red blood cells
and platelets, form a thrombus, or blood clot. This thrombus is
subjected to large shear forces in blood vessels, on the order
of several hundred picoNewtons (pN) (Litvinov et al., 2005).
How the clot is able to withstand these forces determinesStructurewhether it prevents hemorrhage or ruptures resulting in thrombo-
embolism. In order to withstand the shear forces and yet main-
tain its integrity, a clot must exhibit a measure of elasticity
such that it is able to deform reversibly. Laser tweezers (Collet
et al., 2005) and atomic force microscopy (AFM) (Liu et al.,
2006) have been used to stretch individual fibrin fibers, which
have demonstrated considerable elasticity, reversibly stretching
to nearly two to three times their resting length. However, the
molecular basis of this elasticity is still unknown (Weisel, 2004).
Because of the epidemic proportions of cardiothromboembolic
disease, there is an urgency to understand and control the
mechanisms that govern clot elasticity.
Other so-called ‘‘mechanical proteins’’ exhibit intermediate
conformations during unfolding as a means to buffer shear
forces (Li et al., 2002; Marszalek et al., 1999). Based on the ob-
served elasticity of fibrin clots, we hypothesize that such inter-
mediate elastic conformations exist in blood clot components
and serve as shock absorbers to shield the clot from the brunt
of shear forces. The building block of blood clots is fibrinogen,
a bisymmetric heterohexameric molecule that is composed
of two peripheral (C-terminal) D regions connected to a central
(N-terminal) E region by two regions of two-, three-, and four-
stranded coiled a helices (Spraggon et al., 1997; so-called
‘‘coiled coils’’; see Figure 1A). When stretched, force buffering
‘‘intermediates’’ may arise from these coiled-coil regions. For ex-
ample, AFM studies stretching the myosin coiled coil (Root et al.,
2006; Schwaiger et al., 2002), leucine zipper coiled coils (Borns-
chlogl and Rief, 2006), DNA (Cluzel et al., 1996; Rief et al., 1999;
Smith et al., 1996), and desmin intermediate filaments (Kiss et al.,
2006) showed triphasic ‘‘signature’’ force-extension curves,
suggesting that such curves typify molecules with coiled-coil
helical structures. AFM in force spectroscopy mode can there-
fore be used to probe the mechanical characteristics of fibrino-
gen’s coiled coils. However, interpretation of force spectroscopy
experiments of multidomain proteins like fibrinogen becomes
difficult because of the inability to assign force extension signa-
tures to any one region of the molecule.
In order toovercome this difficulty, onemayexploit the fact that
fibrinogenmolecules undergo polymerization in the process of fi-
brin clot formation (Budzynski, 1986; Doolittle, 1984). In fibrin po-
lymerization, the D and E regions of fibrinogen form a complex
that stabilizes these domains (Medved et al., 2001) (see Figures
1B and 1C), thereby increasing the unfolding energies of fibrino-
gen’s central and terminal regions relative to the adjacent coiled
coils. Crosslinking between adjoining D regions by the enzyme
Factor XIII (Lorand, 2001; Lorand et al., 1998) stabilize these16, 449–459, March 2008 ª2008 Elsevier Ltd All rights reserved 449
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Molecular Basis of Fibrin Clot Elasticityregions further and prevent their unfolding (Figure 1C), thus iso-
lating fibrinogen’s coiled coils as primary unfolding elements.
Previous investigators have used protein engineering to design
multidomain proteins in order to amplify the force extension
signal fromunfolding single protein domains and to introduce un-
ambiguous signatures in force-extension profiles (Marszalek
et al., 1999; Oberhauser et al., 1998; Rief et al., 1997). While it is
desirable to create polyproteins of single protein domains, it is
also important to study the mechanical properties of a mul-
timodular protein in its natural biological context, with all its
inherent interdomain interactions. The fibrin protofibril (Fowler
et al., 1981; Medved et al., 1990), where the D and E regions
are likely precluded from unfolding, confers the benefit of study-
ing fibrinogen in its physiological conformation. Naturally arising
protofibrils rather than artificial constructs were therefore also
investigated in this study.
In a bid to reduce ambiguity in AFM force spectroscopy exper-
iments, steeredmolecular dynamics (SMD) simulations (Isralewitz
Figure 1. Fibrinogen Structure and AFM
Imaging
(A) Crystal structure of fibrinogen (PDB code:
1m1j) showing the central E region connected to
the distal D regions by two sets of three-stranded
coiled coils (labeled a1b1g1 and a2b2g2).
(B and C) Schematic diagram of a fibrin protofibril
showing (B) the half staggered double-stranded
configuration and (C) trimodular interactions be-
tween the central E and distal D regions, with
crosslinking between the D regions involving Fac-
tor XIII. Liquid tapping mode AFM images of single
fibrinogenmolecules showing theexpected trinod-
ular structure (D) and fibrin protofibrils showing lin-
ear strands (that are 250 ± 75 nm long (n = 35 pro-
tofibril strands) consisting of seven to ten fibrin
monomers (E)).
et al., 2001; Sotomayor and Schulten,
2007)were carried out to stretch the fibrin-
ogen molecule and provide a view of the
singlemolecule’s response in atomic level
detail. Comparing simulated and mea-
sured force-extension curves permits
one to interpret unfolding events in AFM
force-extension curves in terms of a pro-
tein’s architectural elements (Marszalek
et al., 1999; Ortiz et al., 2005; Rief and
Grubmuller, 2002). By comparingAFMex-
periments andSMDsimulations,we could
indeed identify the signatures to fibrino-
gen’s force-extension curves common to
both approaches and, thereby, verify that
the AFM measurements yielded single fi-
brinogen characteristics. We could also
relate the AFM signatures to specific mo-
lecular transitions of fibrinogen and fibrin
protofibrils.
In addition, we investigated how the
elastic response seen in AFM experi-
ments is modulated by pH and calcium
concentration. The results suggest that
low pH and high calcium concentrations stiffen protofibrils,
opening new pharmacological routes for controlling fibrin clot
elasticity.
RESULTS
AFM Imaging of Fibrin Protofibrils
AFM spectroscopy was performed on single fibrinogen mole-
cules (Figure 1D) and fibrin protofibrils (Figure 1E). AFM images
(obtained in liquid) of single fibrinogen molecules showed the
well-known trinodular shape (Hall and Slayter, 1959; Weisel
et al., 1985), with distinct D and E regions visible. Imaging of fi-
brin protofibrils revealed linear strands of 7–10 fibrin monomers
that are about 250 ± 75 nm (n = 35) long (Figure 1E). The high
resolution obtained in liquid allows the molecular packing of the
fibrin monomers within the protofibril to be discerned. The pu-
rity of fibrinogen in solution used for AFM was verified with
SDS-PAGE (see Figure S1 in the Supplemental Data available
450 Structure 16, 449–459, March 2008 ª2008 Elsevier Ltd All rights reserved
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Molecular Basis of Fibrin Clot Elasticitywith this article online), thus yielding confidence about the na-
ture of the protein being stretched in the force spectroscopy
experiments.
AFM Force Spectroscopy
Pullingsingle fibrinogenmolecules (Figure2A) at physiological pH
of 7.4 and [Ca2+] of 2.5 mM (as used during imaging) produced
force extension curves characterized by three phases (Fig-
ure2B). Thefirst phasecorresponds to straighteningof fibrinogen
from its relaxed conformation. This phase, labeled ‘‘R,’’ is charac-
terized by a ‘‘rise’’ in the force measured by the AFM over a 5–15
nm extension. The second phase, labeled ‘‘P,’’ is a ‘‘plateau’’ in
the force-extension curve in which the molecule extends by 15
nm at a constant force of 60 pN. The third phase, labeled ‘‘E,’’
is characterized by an ‘‘exponential’’ rise of the applied force
with further increased extension. At the beginning of the E phase,
immediately following the P phase, there arises a transient de-
crease in force measured, producing a characteristic ‘‘dip’’ in
the force-extension curve. Figure S5 shows an overlay ofmultiple
AFM force extension curves for both single fibrinogen molecules
and fibrin protofibrils, along with overlays of the RPE triphasic
curves demonstrating consistency of plateau length and height
as well as the presence of the ‘‘dip’’ across multiple trials.
Distributions of plateau forces and lengths for single fibrino-
gen stretching are shown in Figures 2C and 2D based on
a corresponding analysis of the R and P phases. A similar anal-
ysis relating coiled-coil extension and associated R and P
phases had been carried out for myosin stretching (Root et al.,
2006). The two coiled-coil regions in fibrinogen are each 111 res-
idues long, which corresponds to a length of 1113 0.15 nm (rise
per residue along a straight a helix) = 17 nm. On the other hand,
the length of the completely unfolded coiled coil is 1113 0.36 nm
(length per residue of a completely unfolded polypeptide) =
40 nm. This suggests an estimated extension of 40 nm  17
nm = 23 nm upon stretching each set of coiled coils to their max-
imum length, or a 46 nm extension for the two sets of coiled coils
in fibrinogen. In fact, two triphasic ‘‘RPE’’ responses are seen
while stretching single fibrinogen (Figure 2B), each with a plateau
length of approximately 15 nm (Figure 2D). The plateaus in the
force-extension curve reflect the stretching of one (out of two)
of fibrinogen’s coiled-coils. The discrepancy between the mea-
sured extension (15 nm) and the maximal extension (23 nm) is
likely due to the pick-up point of the AFM tip not coinciding
with the protein terminus.
In a second set of AFM experiments, we stretched fibrin pro-
tofibrils. In protofibrils, the D and E regions form a trimodular
complex (Figures 1B and 1C) that is strengthened by Factor
XIII crosslinking adjacent D regions. As described above, such
an arrangement makes unfolding of the D and E regions highly
unlikely, thereby leaving the coiled coils as the main stretchable
element. Indeed, force-extension curves for protofibrils show the
same triphasic response as observed for single fibrinogen mole-
cules but without the dip in force following the P phase. The
triphasic (RPE) response repeats itself in a blunted sawtooth
pattern (Figure 2E), the average plateau force for protofibrils
measuring 130 pN, and the average plateau length measuring
30 nm (Figure 4A). The increase of the plateau force over that
of single fibrinogen (60 pN) is consistent with protofibrils contain-
ing two fibrinogens in parallel, i.e., one expects a doubling of theStructureextension force (Sarkar et al., 2007). The plateau length is close
to the extension for two sets of coiled coils (a1b1g1 and a2b2g2 in
Figure 1A) to be stretched out. One would expect simultaneous
unfolding of all coiled coils in the protofibril producing a single
long plateau as opposed to a blunted sawtooth pattern; how-
ever, there appears to be a mechanism at work that favors se-
quential unfolding. We speculate that a unique structural feature
of fibrinogen may play a role in this mechanism. Specifically, we
implicate a fourth helical strand at the C terminus of each set of
coiled coils, which connects with fibrinogen’s a chain C-terminal
(a-C) regions that lie parallel to the coiled coils, and have been
shown to interact electrostatically (Jung et al., 2003) with the dis-
tal portion of the fibrinogen coiled-coil regions (Brown et al.,
2000, 2007). This interaction may buffer forces between con-
nected fibrinogen molecules and restrict unfolding at any one
time to the length of a single fibrinogen molecule.
When pulling protofibrils, an overall linear increase in force
superimposed on the sequential triphasic (RPE) patterns is ob-
served, as shown in Figure 2E and insets of Figures 4A, 4B,
and 4C. While the specific mechanism underlying the linear in-
crease is unknown, other studies also observed such spring-
like behavior in fibrin fibrils (Collet et al., 2005). The longitudinal
spring constants calculated for ligated fibrin fibers agree closely
with those seen in the fibrin protofibrils stretched here (see the
Supplemental Data).
A recent report (Brown et al., 2007) of AFM experiments on
single-stranded linear fibrinogen oligomers showed a sawtooth
pattern on force extension profiles, some exhibiting plateau
phases. The average peak force reported was higher than re-
corded here (94 pN versus 60 pN). The discrepancy may be
due to higher calcium concentrations (30 mM) used in that study
to induce end-to-end linear oligomerization of fibrinogen. In con-
trast, our study was performed under physiological calcium
concentrations (2.5 mM); indeed, an increased calcium concen-
tration led to an increase in the plateau force as discussed be-
low. The present study employed an arrangement of fibrinogen
polymerized into its natural double-stranded protofibril form,
the in vivo half-staggered arrangement depicted in Figure 1B.
Previous studies had shown that the D:E interactions inherent
in the fibrin protofibril species (see Figure 1C) used in our exper-
iments align the two D regions properly for polymerization to
occur and for Factor XIII to efficiently induce crosslinking (Lor-
and, 2001; Lorand et al., 1998). Such D:E interactions are not
present in single-stranded fibrinogen oligomers, introducing
a potential source of strain on that species during crosslinking
of the end-to-end oligomers that may also explain the higher
peak forces reported in Brown et al. (2007).
When the protofibrils were allowed to relax after stretching, we
observed refolding of the coiled coils. This permitted several
cycles of extension and relaxation; however, fewer coiled coils
refolded with each additional extension-relaxation cycle. The
corresponding force-extension curves, shown in Figure S6 in
Supplemental Data, not observed in Brown et al. (2007), may
have arisen due to our use of a natural fibrin protofibril rather
than an end-to-end oligomer chain.
Molecular Dynamics Simulations
In order to relate the AFM data unambiguously to fibrinogen
stretching, we performed molecular dynamics (MD) simulations.16, 449–459, March 2008 ª2008 Elsevier Ltd All rights reserved 451
Structure
Molecular Basis of Fibrin Clot Elasticity452 Structure 16, 449–459, March 2008 ª2008 Elsevier Ltd All rights reserved
Structure
Molecular Basis of Fibrin Clot ElasticityThe simulations, which stretched fibrinogen in the same manner
as expected in our AFM experiments, reproduced indeed the
force-extension curves seen in the AFM experiments in remark-
able detail (Figure 3A) albeit at higher forces due to the simula-
tions’ higher stretching velocities (Evans and Ritchie, 1997).
The fibh system of whole fibrinogen (see the Experimental Pro-
cedures), consisting of two sets of a-b-g coiled-coil helices, was
stretched at a velocity of 0.025 A˚/ps in simulation simB2 until
both sets of helical domains were fully extended. The resulting
force-extension profile, shown in Figure 3A, reproduces the tri-
phasic ‘‘RPE’’ response observed in the AFM force-extension
trace (Figure 2B). This close agreement is clear evidence that
isolated coiled coils are indeed being stretched in our AFM
experiments. In addition, the simulations revealed that as the
fibrinogen molecule is stretched, the extension occurs in a spe-
cific and orderly pattern, with distinct regions within the coiled
coil unraveling before others. Specifically, the first region to un-
fold is the double a-helix region (comprising the a and b chains)
near the center of the helical domain (Figure 3A, ii). This is fol-
lowed by unfolding of the triple a-helix regions (comprising all
three chains) (see Figure 3A, iii) that flank both ends of the double
a-helix region. When the triple a-helix region is fully extended,
the central domain (or E region) (Figure 3A, iv) of fibrinogen un-
folds despite the presence of disulfide bonds, which were not
disrupted. Finally, the remaining helical region, consisting of
a four a-helix bundle (see Figure 3A, v) at the C terminal, unravels
to complete extension (approximately 21 nm on each side) of the
coiled-coil helix fibrinogen domain. This measured extension is
slightly larger than the plateau length value observed from the
AFM measurements (15 nm).
On closer inspection, the unfolding of coiled coils exhibits
three plateaus, a first one (Figure 3A, ii) corresponding to unrav-
eling two coiled a helices, a second one (Figure 3A, iii) corre-
sponding to unraveling three coiled a helices, and finally a third
one (Figure 3A, v) corresponding to unraveling four coiled a heli-
ces; the second plateau is followed by a dip (Figure 3A, iv) in the
force-extension curve. Snapshots of the unfolding events are
shown in Figure 3B, ii/iii/iv/v, and Figure 3C, ii/iii/iv/v. While the
double and triple a-helical regions from each trimeric half of
fibrinogen extended at approximately the same time, the four
a-helices region for the a1/b1/g1 half extended slightly earlier
than its complementary region on the a2/b2/g2 half. Thus, in
much the same way as a rope with more coiled strands can
bear a higher mechanical load, the architecture of fibrinogen’s
successively coiled a-helical regions lend to it an increasingly
stiff response to pulling forces, such that the double a helices un-ravel first, followed by unraveling of the triple helices and finally of
the C-terminal four a-helices domain.
Simulations of the fibt system (half of a fibrinogen, see Exper-
imental Procedures), in which one set of coiled-coil helices (a1/
b1/g1) was stretched at velocities of 0.05 A˚/ps and 0.025 A˚/ps
(simA2 and simA3, respectively), also revealed a triphasic
(RPE) force-extension curve (Figure S2); however, the curve
does not exhibit the pronounced dip seen for whole fibrinogen
as is to be expected. This demonstrates clearly that the dip
stems from unfolding of the central domain not included in fibt.
The role of the central domain in modulating fibrinogen’s elas-
tic response is not well understood. The domain features
a unique architecture, specifically, contacts between the two
sets of coiled coils at the N-terminal central domain that are
characterized by a network of disulfide bonds and an interlock-
ing arrangement of the N-terminal regions of b chains, which
form a b hairpin, that are each encircled by a loop formed from
the opposing half’s N-terminal a chain (Madrazo et al., 2001;
Weisel, 2005). The b hairpins and a chain form in an a1/b2 and
a2/b1 fashion, binding one half of fibrinogen to the other. This
architecture is shown in Figure S3 at the 0 ns time point before
fibrinogen stretching; the cartoon representation in Figure S3A
depicts the arrangement of the b hairpins wrapped by the
a-chain loops; Figure S3B offers a surface view, which shows
more clearly the extent of contacts between the two sets of
structures. In simB2, following extension of the triple helix do-
mains from both halves of fibrinogen, this central domain begins
to unravel but is constrained by the interlocking arrangement of
the a-chain loops and b-chain hairpins. This unraveling, ob-
served in our simulations at 13–14 ns, is illustrated in Figure S3
in a series of sequential snapshots showing that further unravel-
ing and extension is only possible by pulling the b hairpins free
from the grip of their encircling loops. Once the b hairpins have
broken free from the ‘‘molecular handshake’’ (Weisel, 2005) of
the encircling loops, disulfide bonds (shown at the 14 ns time
point of Figure S3B) between opposing halves of fibrinogen
begin to dominate interactions in the central domain.
The correlation of central domain unraveling and the dip in the
force-extension curves recorded in both AFM experiments and
SMD simulations provides strong evidence that during AFM
stretching of fibrin protofibrils, the central domain does not un-
fold since the dip is not seen, i.e., the extension in protofibrils is
restricted to the coiled-coil regions. Analysis of simB2 in which
whole fibrinogen is stretched reveals that charge-charge and
van der Waals interactions between the termini of coiled coils
at fibrinogen’s central region and the loops of the region’sFigure 2. Geometry of AFM Measurement, with Fibrinogen and Fibrin Force-Extension Curves and Histograms
(A) Diagram illustrating the geometry of the AFM pulling fibrinogen. Initially, the molecule is straightened from its relaxed conformation (R phase). This is followed
by an extension of the coiled-coil region during a P (plateau) phase, endingwith a ‘‘dip’’ in the force. Finally, further extension is characterized by an E (exponential)
phase reflecting a steep rise in the needed force.
(B) Force extension curve for stretching a single fibrinogen molecule, showing the R, P, and E phases. The inset shows the complete force extension curve
obtained for a single fibrinogen molecule depicting two consecutive triphasic signatures, each presumably corresponding to the unfolding of one of the coiled
coils in fibrinogen (see Figure 1A). The rectangle denotes the highlighted region. The expanded figure shows a plateau height of 60 pN and a plateau length of
15 nm. The plateau height was calculated relative to the force baseline before the R phase (see Experimental Procedures). AFM traces demonstrating consistency
of the triphasic RPE response across multiple trials are shown in Figure S5.
(C and D) Histograms showing the plateau force (C) and plateau length (D) distributions (pH 7.4 and calcium concentration of 2.5 mM). Black lines in each histo-
gram are moving averages.
(E) Force-extension curve for the linear polymeric fibrin strands (protofibrils) showing a blunted ‘‘sawtooth’’ pattern of four triphasic coiled-coil signatures exhib-
iting hysteresis (extension in red and relaxation in blue). The AFM data reveal a characteristic force plateau related to the unfolding of the fibrinogen’s coiled coils.
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Molecular Basis of Fibrin Clot Elasticityb hairpins stabilize the central domain and protect it from
unfolding. When fibrinogen is stretched, the central region ex-
periences a continuous force yet does not unravel until the
adjacent helical domains are fully extended. This behavior is
puzzling but can be understood from an inspection of simula-
tion simB2.
Two unfolding barriers play a role in protecting the central
domain against unfolding before the central domain is fully ex-
tended in the P phase. The first barrier is mainly entropic and
arises from the coiled coils inserting into the central domain:
only when these coiled coils are completely unraveled can the
central domain unfold, suggesting that complete coiled-coil un-
raveling leads to a narrow conduit in conformational space, the
entropic barrier or ‘‘eye of the needle,’’ passage through which
triggers the stepwise unraveling of the central domain at the
end of the P phase. The second barrier arises from an enthalpic
contribution due to charge-charge interactions between the
coiled coils and the central domain’s b-hairpin loops; energy re-
quired to dislodge the b hairpins from the loops encircling the
central domain also contributes to the enthalpic barrier.
The dip in the force-extension curve arises after the crossing of
the entropic and enthalpic barriers described, i.e., when the cen-
tral domain unfolds very easily. The crossing of the entropic and
enthalpic barriers coincides with breaking of the b-hairpin/loop
interaction described above. A schematic depiction illustrating
the central domain unfolding (Figure S7) and the charge-charge
and van der Waals interactions between the coiled-coil termini
and the central domain (Figure S8), as well as movies (Movies
S1–S3) of the unfolding/stretching trajectories showing addi-
tional details for all simulations (simA2–simA3, simB2) is pro-
vided in the Supplemental Data.
Although SMD simulations describe well the mechanical be-
havior ofproteinsunder force, it isworthnoting that computational
constraints prevent sampling on the timescale (i.e., seconds) of
actual AFM experiments. Due to faster pulling, SMD simulations
report forces higher than those seen in force spectroscopy; none-
theless, excellent qualitative agreement with experiment is found
in regard to force-extension relationships (Gao et al., 2003; Israle-
witz et al., 2001; Izrailev et al., 1997; Lu et al., 1998; Marszalek
et al., 1999; Ortiz et al., 2005; Rief and Grubmuller, 2002; Soto-
mayor and Schulten, 2007). Indeed, AFM force spectroscopy
combined with SMD simulations succeeds in the present case
to resolve the relationship between protein architecture and pro-
tein elasticity, revealing the role of the coiled coils as the region
of main elasticity.
AFM Spectroscopy under Different pH
and Calcium Concentrations
With the knowledge that coiled coils control fibrinogen’s main
elastic response, one can naturally envision that factors modu-lating the structural properties of the coiled coils can render
blood clots to be either more stiff or more flexible. It is well known
that local pH and ion concentrations affect the mechanical
properties of coiled coils (Bullough et al., 1994; Burkhard et al.,
2001; Kohn et al., 1995a; Kohn et al., 1995b). Therefore, addi-
tional AFM experiments on protofibrils were performed to test
these conditions. At physiological pH (7.4) and calcium concen-
tration (2.5 mM) a plateau force of 130 pN and plateau length
of 30 nm was observed (Figure 4A). When the pH was lowered
to 3.1, the average plateau force increased to 170 pN and
the average plateau length decreased to 20 nm (Figure 4B).
With increase in calcium concentration from 2.5 mM to 10 mM
(Figure 4, bottom), the average plateau force increased to
190 pN, but the average plateau length remained unchanged
at 30 nm.
The pH-dependent elastic response of fibrinogen may be due
to charged interhelical interactions stemming from protonated
residues. In order to identify whether such residues play a role
in stabilizing fibrinogen, the knob-hole residue pairs involved in
the interhelical interactions were identified (see Experimental
Procedures). This revealed several GLU residues (Figure S4A)
that can become protonated at decreased pH, which may be in-
volved in the knob-hole interactions (Kohn et al., 1995a, 1995b)
(Figures S4B–S4D). The calcium-dependent response, on the
other hand, may be due to conformational changes arising
from metal ion coordination sites in the coiled-coil region. Cal-
cium ions have been shown to coordinate intramolecular regions
of proteins, thereby stiffening them against mechanical forces,
a typical example being cadherin (Nagar et al., 1996; Pokutta
et al., 1994; Sotomayor et al., 2005). Indeed, a calcium binding
site has been reported (Kostelansky et al., 2002) between the
coiled coil and the b domain of fibrinogen that could be involved
in an overall stiffening of fibrin protofibrils. The observed effects
(Figure 4C) could also be due to putative calcium binding sites
not yet identified. Further understanding and elucidation of the
molecular mechanism underlying the effects of pH and calcium
on modulating the elasticity of fibrinogen’s coiled coils offer
avenues for future clinical therapy in blood clot management.
For example, modulation of blood pH and administration of
metal chelating agents may decrease the likelihood of thrombo-
embolism for high risk patients.
DISCUSSION
Our experimental-computational study demonstrates the pres-
ence of a force plateau when stretching fibrinogen and relates
the plateaus to an ordered, stepwise unfolding of the protein’s
coiled-coil domains. A triphasic (RPE) response to stretching
seen in single molecules as well as in polymerized fibrin mono-
mers should play a significant role in the mechanical responseFigure 3. Stretching Fibrinogen Using Steered Molecular Dynamics Simulations
(A–C) Force-extension profile of fibrinogen stretched at 0.025 A˚/ps over the course of simulation simB2 (see Table 1). The marked time points along the trace
denote unfolding events highlighted in (B) and (C). (B) Snapshots of unfolding events show (i) the initial equilibrated fibrinogen molecule before stretching at
t = 0 ns; (ii) unfolding of fibrinogen’s double helical region at t = 3.2 ns (blue circles); (iii) unfolding of fibrinogen’s triple helical region at t = 8.5 ns (red circles);
(iv) unraveling of fibrinogen’s central domain at t = 14 ns (green circle); (v) unfolding of the terminal regions made of four helices at t = 18 ns (purple circles);
(vi) full extension of the coiled-coil segments of fibrinogen at t = 22.4 ns. (C) Detailed views of unfolding events in ii–v corresponding to a partially unraveled helical
or central domain region. Disulfide bonds are highlighted through circles in (iv). Unfolding of coiled coils results in a force plateau, while unraveling and unfolding of
the central region gives rise to a ‘‘dip’’ (iv) in the force-extension profile. All snapshots show the protein in cartoon representation, with each subunit colored
differently (water not shown for clarity).
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function in maintaining the integrity of blood clots. Mutations or
pathological alterations (Galanakis, 1992, 1993) to the coiled
coils may interfere with fibrinogen function, changing the elas-
ticity of blood clots and causing life-threatening thromboem-
bolism. Pharmacological intervention, targeting fibrinogen’s
coiled coils to modulate fibrin clot elasticity may alter the risk
for thromboembolism. Our approach emphasizes the power
of a combined experimental-simulation approach to reveal
structure-function relationships in cell biology and biomedi-
cine.
EXPERIMENTAL PROCEDURES
Purification of Fibrinogen
Fibrinogenwaspurifiedaspreviouslydescribed (Limetal., 2003).Briefly, venous
bloodwascollected in15 IU/ml lithium-heparin, centrifugedwithin1hr of collec-
tion at 25603 g for 20min at room temperature to obtain platelet-poor plasma.
Figure 4. Changes in Coiled-Coil Plateau Force and Plateau Length with Changes in pH and Calcium
(A) Representative force-extension curve (left panel) for AFM stretching of fibrinogen protofibrils at physiological pH 7.4 and calcium concentration of 2.5 mM.
The inset in this and subsequent panels shows the raw force-extension curve with an overall linear increase in force. The dashed rectangle denotes the region
highlighted in the main plot. The middle and right panels show the plateau force and plateau length histograms.
(B) Force-extension curve and histograms for stretching protofibrils at pH 3.1.
(C) Force-extension curve and histograms for stretching protofibrils at a calcium concentration of 10mM. (The black lines in each histogram aremoving averages.)
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Structure
Molecular Basis of Fibrin Clot ElasticityThe aliquots of 1–1.5mlwere frozenand storedat80Cuntil used. Theplasma
was then subjected to IF-1 monoclonal antibody affinity chromatography
according to a method described by Takebe and colleagues (Takebe et al.,
1995). Essential for delicate force spectroscopy experiments, this method of
fibrinogen purification avoids bringing proteins to their isoelectric point and
also the harsh conditions inherent in precipitations.
Polymerization of Fibrinogen
Seventy microliters of purified fibrinogen (final concentration 0.1 mg/ml) was
reacted with 10 ml of CaCl2 (2.5 mmol), 10 ml of FXIII (0.002 mg/ml, American
Diagnostica, USA), and 10 ml of thrombin (Lim et al., 2003; 0.1 U/ml, Sigma,
USA), the polymerization being allowed to continue for 3min. Under these con-
ditions, linear strands of seven to ten fibrin monomers can be formed that are
250 nm long. At 3 min, the reaction is stopped by pipetting 10 ml of the clotting
mixture into 90 ml of phosphate buffer solution (PBS; pH 7.4); 80 ml of this
solution was used for AFM. Further details of our approach are provided in
Supplemental Data.
Atomic Force Microscopy of Fibrinogen and Fibrin Protofibrils
A Multimode Picoforce AFM (Veeco, Santa Barbara) was used for imaging
(Lim, 2005; Marchant et al., 1997) and force spectroscopy experiments (see
below). Imaging of protofibrils was performed in liquid tapping mode. This
mode imparts the least amount of force and perturbation on the protein since
the AFM probe is only intermittently in contact with the sample. The protein
samples were placed onto freshly cleaved mica discs, allowed to adsorb for
10 min, rinsed off gently with PBS buffer three times, loaded into the AFM,
and allowed to equilibrate in clean PBS buffer. Imaging utilized oxide sharp-
ened silicon nitride tips with tip radii of 10 nm, resonant frequency of 300
kHz, and spring constant of 0.064 N/m. Imaging parameters were adjusted
to achieve the lowest imaging force possible to avoid sample damage. Image
data were subjected to first order flattening only. Length and height of the
protofibrils were measured by using the built-in analysis program.
Force Spectroscopy with Atomic Force Microscopy
Fibrin protofibrils polymerized from purified fibrinogen in PBS (pH 7.4) were
deposited in separate experiments onto gold sputtered coverslips and allowed
to adsorb for 5 min. Silicon nitride probes (Veeco Instruments) were used. In
order to reduce the possibility of cantilever drift, the Multimode Picoforce
AFM employs a closed loop Z scanner. Furthermore, microscope, sample,
fluid, and cantilever were equilibrated in a climate controlled environment prior
to calibration procedures in order to maintain thermal stability. The spring con-
stant of the cantilever was calibrated with the automated thermal fluctuation
method, resulting in a value of 0.064 N/m. Single molecules were stretched
by first pressing the cantilevers on the gold-coated coverslips for 1 to 3 s at
500 pN to 1 nN (Oesterhelt et al., 2000; Rief et al., 1997). The pulling speed
ranged from 400 nm/s to 1,000 nm/s. A schematic depiction of our experimen-
tal setup is shown in Figure 2A. The success rate for picking up single mole-
cules was approximately 1% over all trials. In separate experiments, fibrin pro-
tofibrils prepared as described above were deposited onto gold-coated
coverslips, and force spectroscopy experiments carried out as described.
Gold-coated coverslips were used because they resulted in a better success
rate than glass coverslips even in the absence of thio-gold bonds.
Force Spectroscopy at Different pH and Calcium Concentrations
The fibrinogen and fibrin protofibril preparations were incubated also in a low
pHPBS buffer (pH 3.1) or high calcium ion concentrations (10mM) for 1 hr. The
solutions were introduced separately, too, into the atomic force microscope,
and the force spectroscopy experiments carried out as described above.
Presentation of AFM Data
The AFM force extension curves for the stretching of single fibrinogen mole-
cules and fibrin protofibrils under normal and modified pH and calcium con-
centration conditions are shown in Figures 2E and 4 (insets), and Figure S5
without modification except for alignment with the positive x and y axes. The
RPE triphasic response in the force-extension curves in Figures 2B and 4
are also shown without modification, except that the overall slope of the
AFM trace had been subtracted to reveal the actual plateau height and length.
The baseline force was normalized to zero at the beginning of the R phaseStructure(Schwaiger et al., 2002). The criteria used to define the R, P, and E phases
of the force extension curve follow the same as those employed in (Kiss
et al., 2006; Root et al., 2006; Schwaiger et al., 2002) in which the change in
slope demarcated the beginning and end of each phase. The beginning of
the R phase was defined as the initial abrupt rise in force transitioning from
the baseline to the plateau. Plateau phases were distinguished by the change
in the slope of the force extension curve going from the R phase to the P phase,
and similarly, the end of the P phase was defined as the change in slope going
into the E phase as illustrated in Figure S5 in Supplemental Data. The three
components had to be clearly discernable before the curves were selected
for analysis. The plateau force was then taken as the force originating at the
beginning of the R phase to the beginning of the P phase. For the RPE triphasic
response shown in Figure S5, multiple plateaus were aligned, and a moving
average was used to filter out the noise from separate AFM trials. The resulting
averaged curve shows clearly the R, P, and E phases.
Search for Knob-Hole Salt Bridge Pairs within the Fibrinogen
Coiled-Coil Structure
Charge-charge interactions, such as those involved in salt bridges, were
identified by taking into account characteristic knobs-into-holes side-chain
packing of coiled coils, coiled-coil helix boundaries, oligomerization states,
helix orientations, and heptad registers. This analysis was performed by using
SOCKET (Walshaw and Woolfson, 2001, 2003) on the crystal structure for the
double D fragment of human fibrin (PDB code: 1fzc) (Everse et al., 1998).
Molecular Dynamics Simulations
The structure of chicken fibrinogen (PDB code: 1m1j) solved crystallographi-
cally at 2.7 A˚ resolution (Yang et al., 2001) was used for two independent
sets of simulations. The first system simulated, denoted fibt, contained
a heterotrimer of the protein made of chains A, B, and C (a1b1g1), essentially
half of a fibrinogenmolecule. The second system, fibh, contained the complete
heterohexameric structure of fibrinogen (a1b1g1 and a2b2g2). fibt and fibh
encompass a total of 367,113 and 1,008,223 atoms, respectively, when placed
in a water box large enough to accommodate the stretched proteins. The
simulations are described in further detail in the Supplemental Data.
All molecular dynamics simulations were performed by using NAMD 2.6
(Phillips et al., 2005) and the CHARMM27 force field for proteins (MacKerell
et al., 1998) along with the TIP3P model for water molecules (Jorgensen
Table 1. Summary of Simulations
Name System Type Ensemble
Atoms
3 1000
SMD
Parameters
Time,
ns
simA1 fibt EQ NpT 367 — 7.0
simA2 fibt SCV NV 367 0.05 A˚/psa 5.0
simA3 fibt SCV NV 367 0.025 A˚/psa 10.0
simB1 fibh EQ NpT 1,018 — 10.0
simB2 fibh SCV NV 1,018 0.025 A˚/psb 22.5
Under type, EQ denotes equilibration, and SCV denotes constant velocity
SMD simulations. The ensemble column lists the variables held constant
during the simulations; N, V, p, and T correspond to number of atoms,
volume, pressure, and temperature, respectively. Footnotes under SMD
parameters describe, in the case of SMD simulations, which atoms
were fixed or had an external force applied to them.
a Fixed the Ca atoms of residues Cys
a50,b85,g23 (on the a, b, and g chains,
respectively), and attached the center of mass of Ca of residues a164–
167, b198–200, g135–137 to a virtual spring of stiffness k = 3 kcal/mol/
A˚2. The coiled coil of half fibrinogen was effectively stretched.
b Fixed the Ca atoms of residues Cys
a162,b198,g135 (corresponding to the
crystallographic chains a2, b2, and g2, respectively) and attached the cen-
ter of mass of Ca of residues a1161–163, b1197–199, g2134–136 (corre-
sponding to crystallographic chains A, B, and C, respectively) to a virtual
spring of stiffness k = 3 kcal/mol/A˚2. The coiled coils and central domain
of a whole fibrinogen molecule were effectively stretched.16, 449–459, March 2008 ª2008 Elsevier Ltd All rights reserved 457
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Molecular Basis of Fibrin Clot Elasticityet al., 1983). Simulations of fibh were performed by using the grid correction
energy map (CMAP) for the F,J angle dynamics of the protein backbone
(Buck et al., 2006; Mackerell et al., 2004). A cutoff of 12 A˚ (switching function
starting at 10 A˚) for van der Waals interactions was assumed, and long-range
electrostatics were calculated by using the particle-mesh-Ewald (PME)
method along with the pencil decomposition protocol (Kumar et al., 2007).
An integration timestep of 1 fs was employed along with a constant tempera-
ture (T = 300 K) control.
The simulations carried out are summarized in Table 1. Equilibrations of fibt
and fibh were achieved in simA1 and simB1, respectively, and followed iden-
tical procedures. The equilibration times ranged from 7 to 10 ns. Steered mo-
lecular dynamics (SMD) simulations utilized the equilibrated structures from
simA1 or simB1. In simA2 and simA3, fibt was stretched at velocities of 0.05
A˚/ps and 0.025 A˚/ps, respectively. In simB2 fibh was stretched at a velocity
of 0.025 A˚/ps. The SMD simulations reached full extension of the fibrinogen
system being examined. The SMD parameters are listed in Table 1.
The overall simulation time reported in this study included 22 ns for the
heterotrimeric fibrinogen system (fibt) and 32.5 ns for the heterohexameric
fibrinogen system (fibh). System coordinates were saved every picosecond,
and analysis was performed by using the program VMD (Humphrey et al.,
1996). Structural changes in the calculated models were monitored by calcu-
lating the RMSD of protein backbone atoms over the course of the simulations.
The end-to-end distance is based on the distance between the pulled and
fixed Ca atoms. The extension is defined as the change of the end-to-end
distance of the system.
SUPPLEMENTAL DATA
Supplemental Data include further details of experimental and computational
procedures along with supporting analyses of atomic force microscopy and
molecular dynamics simulations and are available at http://www.structure.
org/cgi/content/full/16/3/449/DC1/.
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